Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Glioma: Biomolecular Aspects

NCT05806619

Conditions: Glioma, Glioma, Malignant, Neoplasms, +6 more
Locations: San Giovanni Addolorata Hospital Rome, Roma, Italy

"Regina Elena" National Cancer Institute Rome, Italy

View Trial Details

Completed

Study of Alpha-blockers Alone During Preoperative Preparation in Patients With Pheochromocytoma

NCT05803330

Conditions: Adrenal Pheochromocytoma, Hemodynamic, Neoplasms, +7 more
Locations: Not specified

View Trial Details

Completed

Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor Burden

NCT05611229

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Novartis Investigative Site East Hanover, New Jersey, United States

View Trial Details

Completed

CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG) (PNOC 009)

NCT03086616

Conditions: Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +15 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation

NCT02186678

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Assistance Publique Hopitaux de Marseille Marseille, France

View Trial Details

Completed

A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic Melanoma

NCT01164891

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Zurich, Switzerland

View Trial Details

Completed

A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas

NCT04089449

Conditions: Advanced Solid Tumor, Glioma, Neoplasms, +7 more
Locations: Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

Yale- New Haven Hospital- Yale Cancer Center New Haven, Connecticut, United States

Christiana Care Health Services, Christiana Hospital Newark, Delaware, United States

Florida Cancer Specialists Lake Mary, Florida, United States

View Trial Details

Completed

Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery

NCT02120222

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors

NCT00442533

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoma, +19 more
Locations: Excel Diagnostic Imaging Clinics Houston, Texas, United States

St. Lukes Episcopal Hospital Houston, Texas, United States

View Trial Details

Completed

Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors

NCT02588170

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

the 307 Hospital of People's Liberation Army Beijing, Beijing Municipality, China

Beijing Cancer Hospital Beijing, Beijing Municipality, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions